Target Price | $103.33 |
Price | $8.04 |
Potential |
1,185.24%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Aligos Therapeutics Inc 2025 .
The average Aligos Therapeutics Inc target price is $103.33.
This is
1,185.24%
register free of charge
$175.00
2,076.62%
register free of charge
$60.00
646.27%
register free of charge
|
|
A rating was issued by 3 analysts: 3 Analysts recommend Aligos Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Aligos Therapeutics Inc stock has an average upside potential 2025 of
1,185.24%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 15.53 | 2.60 |
11.65% | 83.26% | |
Net Margin | -700.65% | -1,073.56% |
1,257.86% | 53.22% |
3 Analysts have issued a sales forecast Aligos Therapeutics Inc 2024 . The average Aligos Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -34.11 | -8.75 |
1,416.00% | 74.35% | |
P/E | negative | |
EV/Sales | negative |
Based on analysts' sales estimates for 2024, the Aligos Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Aligos Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.